ID Logistics Stock Quote IDL - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

441.00

Bid

441.00

Ask

443.00

Volume

4,074

441.00 Day's Range 455.50

225.00 52 Week Range 459.50

Market Cap

2.722B

Previous Close

443.50

Open

455.50

Last Trade

441

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

4,038

Shares Outstanding

6,173,328

Dividend Yield

PE Ratio

52.21

Earnings Per Share (EPS)

8.45

Revenue

2.76B

Net Profit

52.14M

Sector

Management Consulting Svcs

Industry

Management Consulting Svcs

Website

www.id-logistics.com

Headquarters

Orgon, Fra

Founded

1970

ID Logistics Group is listed in the Management Consulting Svcs sector of the Euronext with ticker IDL. The last closing price for ID Logistics was 443.50 €. Over the last year, ID Logistics shares have traded in a share price range of 225.00 € to 459.50 €.

ID Logistics currently has 6,173,328 shares outstanding. The market capitalization of ID Logistics is 2.74 € billion. ID Logistics has a price to earnings ratio (PE ratio) of 52.21.

FeaturedCannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Atea Pharmaceuticals Presents Positive Initial Phase 2 Data for Bemnifosbuvir and Ruzasvir Combination for Treatment of Hepatitis C Virus at EASL Congress 2024

97% SVR12 Rate Observed with 8 Weeks of Treatment in Lead-In Cohort of HCV-Infected Patients in Ongoing Phase 2 Clinical Study EASL Presentations Continue to Support Best-in-Class Potential with...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference

BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral...

Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024

Presentations to Include New Antiviral Efficacy Results, Including SVR12 Data, from Lead-In Cohort of Ongoing Phase 2 HCV Trial Data Also Highlight the High Prevalence of Pre-Existing NS5A...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	33	8.08823529412	408	459.5	407.5	4176	433.92775037	DE
4	79.5	21.9917012448	361.5	459.5	361.5	3373	405.1527961	DE
12	98	28.5714285714	343	459.5	340	4038	384.85549305	DE
26	114.5	35.0689127106	326.5	459.5	316.5	3971	358.92574999	DE
52	183.5	71.2621359223	257.5	459.5	225	3468	322.60218756	DE
156	172.5	64.2458100559	268.5	459.5	225	2904	303.21484029	DE
260	265.6	151.425313569	175.4	459.5	115	2643	266.94665798	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MLIDSIds	0.454 € (51.33%)	4k
ALJXRArchos	0.151 € (37.27%)	5.64M
GNROGeNeuro SA	0.0728 € (20.13%)	52.3k
LIGLisgrafica	0.006 € (20.00%)	2.84k
AXWDSAxway Software	1.875 € (19.81%)	16.68k
LOCALSolocal Groupe	0.0097 € (-62.69%)	30.74M
ALCYBCybergun	0.0001 € (-50.00%)	43.64M
OXUROxurion NV	0.0001 € (-50.00%)	133.72M
MLSGTSmart Good Things Holding SA	1.78 € (-45.73%)	420
ALNEVNeovacs	0.0133 € (-42.92%)	10.27M
ALSAFSAFE	0.0004 € (0.00%)	211.04M
OXUROxurion NV	0.0001 € (-50.00%)	133.72M
ALCYBCybergun	0.0001 € (-50.00%)	43.64M
LOCALSolocal Groupe	0.0097 € (-62.69%)	30.74M
BCPBanco Comercial Portugues SA	0.3861 € (0.42%)	29.22M